Is RBBB More Indicative of Large Anteroseptal MI?
Colchicine is known to be effective in treatment of recurrent pericarditis, but until recently its efficacy during the first attack of acute pericarditis has been uncertain.
A recent multicenter, double-blinded, RCT of patients with acute pericarditis found colchicine to be effective in reducing the rate of incessant or recurrent pericarditis (primary outcome), as well as the rate of hospitalization. Here are some highlights:
Bottom-line:
Colchicine is a safe and effective drug for the treatment of acute pericarditis. Consider adding colchicine to conventional therapies to reduce duration of symptoms, recurrences, and rate of hospitalization.
*Please see the attachment below for Figures A-D
Adult ED patients are commonly found to have markedly elevated blood pressures (>160/100) without any signs or symptoms of acute organ injury (ie, cardiovascular, renal, or neurological).
A recently revised ACEP clinical policy aims to guide emergency physicians in the evaluation and management of such patients.
They make the following recommendations (Level C):
Bottom-line:
There's little evidence to guide the decision of which patients with markedly elevated blood pressures to test or treat in the ED. This new clinical policy suggests that routine screening and treatment is not required. Asymptomatic patients should be referred for close follow-up, but consider a BMP in patients with poor follow up.
Want more emergency cardiology pearls? Follow me @alifarzadmd
Tight glycemic control (HbA1C<7%) has previously been recommended in CAD based on data from the United Kingdom Prospective Diabetes Study (UKPDS)
A recent study (JACC) evaluated the relationship between glycemic control, cardiovascular disease (CVD) risk, and all-cause mortality
Patients with a mean HbA1C 7-7.4% were compared to those with mean HbA1C <6%; tight glycemic control had a 68% increased risk of CVD hospitalization
Lenient HbA1C>8.5% also had significantly higher risk
CVD risk and all-cause mortality is greater with both aggressive and lax glycemic control and the optimal reference range may lie between 7-7.4%
Radiation therapy is frequently utilized in the management of numerous thoracic malignancies
Cardiovascular disease is now the leading cause of nonmalignancy death in radiation-treated cancer survivors
The spectrum of radiation-induced cardiac disease is broad
The relative risk of CAD, CHF, pericardial/valvular disease, and conduction abnormalities is particularly increased
Early identification of potential cardiac complications w/cardiac MR and echocardiography provides an opportunity for regular assessment and potentially improved long term mortality
Bifascicular block
Incomplete Trifascicular block
Complete Trifascicular block
Stanford type A (proximal) aortic dissection accounts for ~60% of all aortic dissections
Classic treatment includes direct surgical replacement of the ascending aorta w/prosthetic graft (+/- AV aortic repair/replacement)
~20-30% of these patients (*institutional dependent) are considered poor candidates for surgery and receive only medical management, which innately results in substandard outcomes
In this study those who were considered poor candidates for surgical repair underwent novel endovascular treatment
Endovascular repair in this study was considered both appropriate and improved traditional medical outcomes in patients who were considered poor candidates